Geode Capital Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91.9M | Sell |
|
|||||
|
2025
Q1 | $70.8M | Buy |
|
|||||
|
2024
Q4 | $43.4M | Sell |
|
|||||
|
2024
Q3 | $45.1M | Sell |
|
|||||
|
2024
Q2 | $38M | Buy |
|
|||||
|
2024
Q1 | $35.9M | Buy |
|
|||||
|
2023
Q4 | $27.2M | Buy |
|
|||||
|
2023
Q3 | $55.8M | Buy |
|
|||||
|
2023
Q2 | $38.5M | Buy |
|
|||||
|
2023
Q1 | $25.5M | Buy |
|
|||||
|
2022
Q4 | $34.7M | Buy |
|
|||||
|
2022
Q3 | $17.8M | Buy |
|
|||||
|
2022
Q2 | $4.42M | Buy |
|
|||||
|
2022
Q1 | $6.29M | Buy |
|
|||||
|
2021
Q4 | $8.81M | Buy |
|
|||||
|
2021
Q3 | $8.44M | Buy |
|
|||||
|
2021
Q2 | $8.99M | Buy |
|
|||||
|
2021
Q1 | $7.67M | Buy |
|
|||||
|
2020
Q4 | $6.23M | Buy |
|
|||||
|
2020
Q3 | $7.2M | Buy |
|
|||||
|
2020
Q2 | $3.49M | Buy |
|
|||||
|
2020
Q1 | $2.41M | Buy |
|
|||||
|
2019
Q4 | $1.76M | Buy |
|
|||||
|
2019
Q3 | $1.7M | Buy |
|